09.15.23 -- 4 Ways For An Edge In the Talent Shortage

Is the growing demand for small molecule outsourcing impeding your ability to find a reliable partner with capacity? Don’t miss Outsourced Pharma Capacity Update — a virtual event focused entirely on the available capacity and related service area capabilities, volumes, locations, and facilities of CDMOs. This multiday event is conveniently grouped by molecule type and will feature small molecule partner presentations on October 4th. Registration is free.

Andrew Trigwell of Paradigm BioPharmaceuticals in Australia, deals in distances. He can teach you how long-distance outsourcing can work, and how to meet the challenges of a global supply chain.

Weichang Zhou, president of global biologics development and operations and CTO, sits down with Outsourced Pharma chief editor Louis Garguilo at the CDMO Leadership Awards to discuss WuXi Biologics' win in the Capabilities category, the role of technology in outsourcing, and how today's partners are focused on innovation. Congratulations again, Weichang and WuXi!

PBPK modeling advancements are helping to identify poor absorption properties early in development, enabling sponsors to mitigate risk in preclinical and clinical studies.

Nanoparticle engineering has emerged as a promising solution to enhance drug solubility and bioavailability and thus improve efficiency within the drug development pipeline.

As highly potent APIs become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

A CDMO with deep team expertise in developing and manufacturing injectable products “from bench to batch” can help ensure that you complete your project on time.

Learn how to navigate the complex clinical supply distribution landscape within this important and growing region.

Explore the three phases of sterile injectable project tech transfer, including how to bridge information gaps and facilitate successful regulatory filing during this stage.

Taste, smell, and mouthfeel are key features for pediatric formulations. Cost-effective solutions with flexibility in manufacturing are essential to overcome challenges.

Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.

The Outsourced Pharma newsletter delivers daily outsourcing insights for specific therapeutic modalities. On Mondays and Thursdays, we cover Biologics outsourcing. On Tuesdays, Cell & Gene Therapies. And on Wednesdays and Fridays, Small Molecule Drugs. Update your topic preferences to receive the newsletter(s) of interest to you.